Last reviewed · How we verify

NCT03837080: NutChROPain

Nutrition Intervention for Chronic Pain Patients

Completed NA Last updated 13 February 2020
What this trial tests

NA trial testing Nutrition Education in Chronic Pain in 67 participants. Completed in 12 February 2020.

Timeline
28 January 2019
Primary endpoint
15 January 2020
12 February 2020

Quick facts

Lead sponsorJosip Juraj Strossmayer University of Osijek
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment67
Start date28 January 2019
Primary completion15 January 2020
Estimated completion12 February 2020
Sites1 location across Croatia

Drugs / interventions tested

Conditions studied

Sponsor

Josip Juraj Strossmayer University of Osijek

Who can join

Adults 18 to 80, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the study is to determine the effectiveness of nutrition education (individual and group) on the intensity of pain in patients suffering from chronic pain. The secondary goal is to determine whether there is a change in the status of the patient's nutrition, their quality of life, quality of life, and other indicators of the psychophysical condition of the patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Nutrition Education

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Josip Juraj Strossmayer University of Osijek trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03837080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing